HEADER MEMBRANE PROTEIN 13-OCT-21 7VOD TITLE CRYSTAL STRUCTURE OF 5-HT2AR IN COMPLEX WITH CARIPRAZINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 5-HT-2,5-HT-2A,SEROTONIN RECEPTOR 2A,CYTOCHROME B-562; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HTR2A, HTR2, CYBC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS GPCR, DOPAMINE RECEPTOR, SEROTONIN RECEPTOR, CARIPRAZINE, KEYWDS 2 ANTIPSYCHOTIC, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Z.CHEN,L.FAN,H.WANG,J.YU,D.LU,J.QI,F.NIE,Z.LUO,Z.LIU,J.CHENG,S.WANG REVDAT 4 29-NOV-23 7VOD 1 REMARK REVDAT 3 16-FEB-22 7VOD 1 JRNL REVDAT 2 29-DEC-21 7VOD 1 COMPND REMARK REVDAT 1 22-DEC-21 7VOD 0 JRNL AUTH Z.CHEN,L.FAN,H.WANG,J.YU,D.LU,J.QI,F.NIE,Z.LUO,Z.LIU, JRNL AUTH 2 J.CHENG,S.WANG JRNL TITL STRUCTURE-BASED DESIGN OF A NOVEL THIRD-GENERATION JRNL TITL 2 ANTIPSYCHOTIC DRUG LEAD WITH POTENTIAL ANTIDEPRESSANT JRNL TITL 3 PROPERTIES. JRNL REF NAT.NEUROSCI. V. 25 39 2022 JRNL REFN ISSN 1097-6256 JRNL PMID 34887590 JRNL DOI 10.1038/S41593-021-00971-W REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12-2829-000 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.42 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 7475 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 381 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 3.3850 - 3.3000 0.82 456 28 0.3510 0.3730 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.437 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 77.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.67000 REMARK 3 B22 (A**2) : 4.89000 REMARK 3 B33 (A**2) : -6.57000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7VOD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 15-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1300020128. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUL-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5-7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL45XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : M REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7889 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.300 REMARK 200 RESOLUTION RANGE LOW (A) : 48.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 14.20 REMARK 200 R MERGE (I) : 0.27300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 1.25000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6A93 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS/HCL, 100 MM POTASSIUM REMARK 280 FORMATE, 30% PEG, LIPIDIC CUBIC PHASE, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,-Y,-Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 25.13500 REMARK 290 SMTRY2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 90.14500 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 25.13500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 90.14500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 MG MG A1201 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 67 REMARK 465 GLY A 68 REMARK 465 THR A 69 REMARK 465 HIS A 70 REMARK 465 LEU A 71 REMARK 465 GLN A 72 REMARK 465 GLU A 73 REMARK 465 ILE A 181 REMARK 465 HIS A 182 REMARK 465 HIS A 183 REMARK 465 SER A 184 REMARK 465 ARG A 185 REMARK 465 PHE A 186 REMARK 465 ASN A 187 REMARK 465 GLY A 1061 REMARK 465 SER A 1062 REMARK 465 GLY A 1063 REMARK 465 SER A 1064 REMARK 465 GLY A 1065 REMARK 465 ASN A 402 REMARK 465 LYS A 403 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 74 CG CD CE NZ REMARK 470 TRP A 76 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 76 CZ3 CH2 REMARK 470 ASN A 179 CG OD1 ND2 REMARK 470 ASP A1066 CG OD1 OD2 REMARK 470 ASP A1074 CG OD1 OD2 REMARK 470 LYS A1083 CG CD CE NZ REMARK 470 LYS A1085 CG CD CE NZ REMARK 470 GLN A1093 CG CD OE1 NE2 REMARK 470 TYR A1101 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE A1102 CG1 CG2 CD1 REMARK 470 LYS A1104 CG CD CE NZ REMARK 470 TYR A1105 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A 313 CG CD OE1 NE2 REMARK 470 LYS A 320 CG CD CE NZ REMARK 470 LYS A 323 CG CD CE NZ REMARK 470 GLU A 351 CG CD OE1 OE2 REMARK 470 LYS A 385 CG CD CE NZ REMARK 470 LYS A 400 CG CD CE NZ REMARK 470 GLU A 401 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 106 48.51 -92.09 REMARK 500 TYR A 139 -3.04 80.60 REMARK 500 CYS A 349 65.73 -114.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CLR A 1203 REMARK 610 OLC A 1204 REMARK 610 OLC A 1205 REMARK 610 OLC A 1206 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1201 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A1008 OE2 REMARK 620 2 GLU A1008 OE2 0.0 REMARK 620 3 ASP A1012 OD1 131.3 131.3 REMARK 620 4 ASP A1012 OD2 97.8 97.8 60.1 REMARK 620 5 ASP A1012 OD1 131.3 131.3 0.0 60.1 REMARK 620 6 ASP A1012 OD2 97.8 97.8 60.1 0.0 60.1 REMARK 620 N 1 2 3 4 5 DBREF 7VOD A 70 265 UNP P28223 5HT2A_HUMAN 70 265 DBREF 7VOD A 1001 1040 UNP P0ABE7 C562_ECOLX 23 62 DBREF 7VOD A 1066 1106 UNP P0ABE7 C562_ECOLX 88 128 DBREF 7VOD A 313 403 UNP P28223 5HT2A_HUMAN 313 403 SEQADV 7VOD GLY A 67 UNP P28223 EXPRESSION TAG SEQADV 7VOD GLY A 68 UNP P28223 EXPRESSION TAG SEQADV 7VOD THR A 69 UNP P28223 EXPRESSION TAG SEQADV 7VOD LYS A 162 UNP P28223 SER 162 ENGINEERED MUTATION SEQADV 7VOD TRP A 164 UNP P28223 MET 164 ENGINEERED MUTATION SEQADV 7VOD TRP A 1007 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 7VOD GLY A 1061 UNP P0ABE7 LINKER SEQADV 7VOD SER A 1062 UNP P0ABE7 LINKER SEQADV 7VOD GLY A 1063 UNP P0ABE7 LINKER SEQADV 7VOD SER A 1064 UNP P0ABE7 LINKER SEQADV 7VOD GLY A 1065 UNP P0ABE7 LINKER SEQADV 7VOD ILE A 1098 UNP P0ABE7 ARG 120 ENGINEERED MUTATION SEQADV 7VOD ILE A 1102 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 7VOD GLY A 1106 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQADV 7VOD ASN A 372 UNP P28223 SER 372 ENGINEERED MUTATION SEQRES 1 A 376 GLY GLY THR HIS LEU GLN GLU LYS ASN TRP SER ALA LEU SEQRES 2 A 376 LEU THR ALA VAL VAL ILE ILE LEU THR ILE ALA GLY ASN SEQRES 3 A 376 ILE LEU VAL ILE MET ALA VAL SER LEU GLU LYS LYS LEU SEQRES 4 A 376 GLN ASN ALA THR ASN TYR PHE LEU MET SER LEU ALA ILE SEQRES 5 A 376 ALA ASP MET LEU LEU GLY PHE LEU VAL MET PRO VAL SER SEQRES 6 A 376 MET LEU THR ILE LEU TYR GLY TYR ARG TRP PRO LEU PRO SEQRES 7 A 376 SER LYS LEU CYS ALA VAL TRP ILE TYR LEU ASP VAL LEU SEQRES 8 A 376 PHE SER THR ALA LYS ILE TRP HIS LEU CYS ALA ILE SER SEQRES 9 A 376 LEU ASP ARG TYR VAL ALA ILE GLN ASN PRO ILE HIS HIS SEQRES 10 A 376 SER ARG PHE ASN SER ARG THR LYS ALA PHE LEU LYS ILE SEQRES 11 A 376 ILE ALA VAL TRP THR ILE SER VAL GLY ILE SER MET PRO SEQRES 12 A 376 ILE PRO VAL PHE GLY LEU GLN ASP ASP SER LYS VAL PHE SEQRES 13 A 376 LYS GLU GLY SER CYS LEU LEU ALA ASP ASP ASN PHE VAL SEQRES 14 A 376 LEU ILE GLY SER PHE VAL SER PHE PHE ILE PRO LEU THR SEQRES 15 A 376 ILE MET VAL ILE THR TYR PHE LEU THR ILE LYS SER LEU SEQRES 16 A 376 GLN LYS GLU ALA ALA ASP LEU GLU ASP ASN TRP GLU THR SEQRES 17 A 376 LEU ASN ASP ASN LEU LYS VAL ILE GLU LYS ALA ASP ASN SEQRES 18 A 376 ALA ALA GLN VAL LYS ASP ALA LEU THR LYS MET ARG ALA SEQRES 19 A 376 ALA ALA LEU ASP ALA GLY SER GLY SER GLY ASP ILE LEU SEQRES 20 A 376 VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU ALA ASN GLU SEQRES 21 A 376 GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA GLU GLN LEU SEQRES 22 A 376 LYS THR THR ILE ASN ALA TYR ILE GLN LYS TYR GLY GLN SEQRES 23 A 376 SER ILE SER ASN GLU GLN LYS ALA CYS LYS VAL LEU GLY SEQRES 24 A 376 ILE VAL PHE PHE LEU PHE VAL VAL MET TRP CYS PRO PHE SEQRES 25 A 376 PHE ILE THR ASN ILE MET ALA VAL ILE CYS LYS GLU SER SEQRES 26 A 376 CYS ASN GLU ASP VAL ILE GLY ALA LEU LEU ASN VAL PHE SEQRES 27 A 376 VAL TRP ILE GLY TYR LEU ASN SER ALA VAL ASN PRO LEU SEQRES 28 A 376 VAL TYR THR LEU PHE ASN LYS THR TYR ARG SER ALA PHE SEQRES 29 A 376 SER ARG TYR ILE GLN CYS GLN TYR LYS GLU ASN LYS HET MG A1201 1 HET CLR A1202 28 HET CLR A1203 20 HET OLC A1204 12 HET OLC A1205 20 HET OLC A1206 18 HET CLR A1207 28 HET 7RU A1208 28 HETNAM MG MAGNESIUM ION HETNAM CLR CHOLESTEROL HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM 7RU 3-[4-[2-[4-[2,3-BIS(CHLORANYL)PHENYL]PIPERAZIN-1- HETNAM 2 7RU YL]ETHYL]CYCLOHEXYL]-1,1-DIMETHYL-UREA HETSYN OLC 1-OLEOYL-R-GLYCEROL HETSYN 7RU CARIPRAZINE FORMUL 2 MG MG 2+ FORMUL 3 CLR 3(C27 H46 O) FORMUL 5 OLC 3(C21 H40 O4) FORMUL 9 7RU C21 H32 CL2 N4 O HELIX 1 AA1 TRP A 76 GLU A 102 1 27 HELIX 2 AA2 LYS A 103 GLN A 106 5 4 HELIX 3 AA3 ASN A 107 LEU A 126 1 20 HELIX 4 AA4 LEU A 126 LEU A 136 1 11 HELIX 5 AA5 SER A 145 ALA A 176 1 32 HELIX 6 AA6 ARG A 189 MET A 208 1 20 HELIX 7 AA7 MET A 208 LEU A 215 1 8 HELIX 8 AA8 ASP A 231 ALA A 1020 1 55 HELIX 9 AA9 ALA A 1023 ALA A 1040 1 18 HELIX 10 AB1 ILE A 1067 GLY A 1082 1 16 HELIX 11 AB2 LYS A 1083 GLU A 1092 1 10 HELIX 12 AB3 GLN A 1093 CYS A 349 1 51 HELIX 13 AB4 ASN A 354 ASN A 384 1 31 HELIX 14 AB5 ASN A 384 ILE A 395 1 12 SHEET 1 AA1 2 PHE A 222 LYS A 223 0 SHEET 2 AA1 2 SER A 226 CYS A 227 -1 O SER A 226 N LYS A 223 SSBOND 1 CYS A 148 CYS A 227 1555 1555 1.95 SSBOND 2 CYS A 349 CYS A 353 1555 1555 2.01 LINK OE2 GLU A1008 MG MG A1201 1555 1555 1.97 LINK OE2 GLU A1008 MG MG A1201 1555 2356 1.96 LINK OD1 ASP A1012 MG MG A1201 1555 1555 2.19 LINK OD2 ASP A1012 MG MG A1201 1555 1555 2.17 LINK OD1 ASP A1012 MG MG A1201 1555 2356 2.19 LINK OD2 ASP A1012 MG MG A1201 1555 2356 2.17 CRYST1 50.270 55.040 180.290 90.00 90.00 90.00 P 21 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019893 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018169 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005547 0.00000